Ocular safety and pharmacokinetics study of FK506 suspension eye drops after corneal transplantation

Journal of Ocular Pharmacology and Therapeutics

Volumn 28, Issue 2, 2012, Pages 153-158

  Yuan, Jin ^a   Zhai, Jia Jie ^b   Huang, Xi ^a   Zhou, Shi You ^a   Chen, Jia Qi ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b Institute of Ophthalmology and Visual Sciences of Guangdong Province   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EYE DROPS; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORNEA TRANSPLANTATION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MEGADOSE; DRUG SAFETY; ENUCLEATION; HISTOPATHOLOGY; LOW DRUG DOSE; NONHUMAN; RABBIT;

ANIMALS; CORNEA; CORNEAL TRANSPLANTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; EYE ENUCLEATION; IMMUNOSUPPRESSIVE AGENTS; OPHTHALMIC SOLUTIONS; RABBITS; SUSPENSIONS; TACROLIMUS; TISSUE DISTRIBUTION;

EID: 84859388731     PISSN: 10807683     EISSN: 15577732     Source Type: Journal    
DOI: 10.1089/jop.2011.0108     Document Type: Article

References (17)

1. Kino, T., Hatanake, H., Hashimoto, M., et al. FK-506, a novelimmunosuppressant isolated from a Streptomyces. I. Fermentation,isolation, and physico-chemical and biological characteristics. J. Antibiot. (Tokyo) 1987;40:1249-1255. (Pubitemid 17138109)
2. Jensik, S.C. Tacrolimus (FK 506) in kidney transplantation: Three-year survival results of the US multicenter, randomized, comparative trial. FK 506 Kidney Transplant Study Group. Transplant Proc. 1998;30:1216-1218. (Pubitemid 28309546)
3. O'Grady, J.G., Burroughs, A., Hardy, P., et al. Tacrolimus versus microemulsified ciclosporin in liver transplantation: The TMC randomised controlled trial. Lancet 2002;360:1119-1125.
4. Griffith, B.P.,Bando, K., Hardesty, R.L., et al. A prospective randomized trial of FK506 versus cyclosporine after human pulmonary transplantation. Transplantation 1994;57:848-851. (Pubitemid 24114675)
5. Ligtenberg, G., Hene, R.J., Blankestijn, P.J., et al. Cardiovascular risk factors in renal transplant patients: Cyclosporin A versus tacrolimus. J. Am. Soc. Nephrol. 2001;12:368-373. (Pubitemid 32116380)
6. Textor, S.C., Weisner, R., Wilson, D.J., et al. Systemic and renal hemodynamic differences between FK506 and cyclo-sporine in liver transplant recipients. Transplantation 1993;55: 1332-1339. (Pubitemid 23183247)
7. Friemann, S., Feuring, E., Padberg, W., et al. Improvement of nephrotoxicity, hypertension, and lipid metabolism after conversion of kidney transplant recipients from cyclosporine to tacrolimus. Transplant Proc. 1998;30:1240-1242. (Pubitemid 28309556)
8. Shaw, K.T.Y., Ho, A.M., Raghavan, A., et al. Immuno-suppressive drugs prevent a rapid dephosphorylation of transcription factor NFAT 1 in stimulated immune cells. Proc. Natl. Acad. Sci. USA 1995;92:11205-11209.
9. Ruff, V.A., and Leach KL. Direct demonstration of NFATp dephosphorlation and nuclear localization in ctivated HT-2 cells using a specific NFATp polyclonal antibody. J. Biol. Chem. 1995;270:22602-22607.
10. Tamura, K., Fujimura, T., Iwasaki, K., et al. Interaction of tacrolimus(FK506) and its metabolites with FKBP and cal-cineurin. Biochem. Biophys. Res. Commun. 1994;202:437-443.
11. Kobayashi, C., Kanai, A., Nakajuima, A., et al. Suppression of corneal graft rejection in rabbits by a new immunosuppres-sive agent, FK-506. Transplant Proc. 1989;21(1 Pt 3):3156-3158. (Pubitemid 19124697)
12. Yuan, J., Zhai, J.J., Chen, J.Q., et al. Preparation of 0.05% FK506 suspension eyedrops and its pharmacokinetics after topical ocular administration. J. Ocular Pharmacol. Ther. 2009; 25:345-350.
13. Yuan, J., Chen, J.Q., Xie, Z.Y., et al. Determination of tacrolimus in rabbit aqueous humor by liquid chromatog-raphy-electrospray ionization tandem mass spectrometry. J. Chromatogr. B 2008;868:34-41.
14. Thomson AW. Interspecies comparison of the immunosup-pressive efficacy and safety of FK506. Transplant Proc. 1990;22:100-105. (Pubitemid 20112768)
15. Pleyer, U., Lutz, S., Juske, W.J., et al. Ocular absorption of to-pocally applied FK506 from liposomal and oil formulations in the rabbit eye. Invest. Ophthalmol. Vis. Sci. 1993;34:2737-2742. (Pubitemid 23232483)
16. Scott, L.J., McKeage, K., Keam, S.J., et al. Tacrolimus: A further update of its use in the management of organ transplantation. Drugs 2003;63:1247-1297. (Pubitemid 36750952)
17. Fujita, E., Teramura, Y., Shiraga, T., et al. Pharmacokinetics and tissue distribution of tacrolimus (FK506) after a single or repeated ocular instillation in rabbits. J. Ocul. Pharmacol. Ther. 2008;24:309-319. (Pubitemid 351735875)